Related Experiment Video
Updated: Jul 2, 2025
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
Research progress of SWI/SNF complex in breast cancer
Kexuan Li1, Baocai Wang2, Haolin Hu3
1School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Abstract:
In the past decade, numerous epigenetic mechanisms have been discovered to be associated with cancer. The mammalian SWI/SNF complex is an ATP-dependent chromatin remodeling complex whose mutations are associated with various malignancies including breast cancer. As the SWI/SNF complex has become one of the most commonly mutated complexes in cancer, targeting epigenetic mutations acquired during breast cancer progress is a potential means of improving clinical efficacy in treatment strategies. This article reviews the composition of the SWI/SNF complex, its main roles and research progress in breast cancer, and links these findings to the latest discoveries in cancer epigenomics to discuss the potential mechanisms and therapeutic potential of SWI/SNF in breast cancer.
Insights
Mutations in the SWI/SNF complex are common in breast cancer. Targeting these epigenetic changes offers a promising therapeutic strategy for improving treatment efficacy.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic mechanisms play a crucial role in cancer development.
- The mammalian SWI/SNF complex is frequently mutated in various cancers, including breast cancer.
- SWI/SNF complex mutations are among the most common in cancer.
Purpose of the Study:
- To review the SWI/SNF complex's composition and roles in breast cancer.
- To connect SWI/SNF findings with recent cancer epigenomics discoveries.
- To discuss the therapeutic potential of targeting SWI/SNF in breast cancer.
Main Methods:
- Literature review of SWI/SNF complex in breast cancer.
- Analysis of current research on cancer epigenomics.
- Synthesis of findings to explore therapeutic strategies.
Main Results:
- The SWI/SNF complex is a key player in chromatin remodeling.
- Mutations in SWI/SNF are significantly associated with breast cancer progression.
- Targeting epigenetic alterations in SWI/SNF presents therapeutic opportunities.
Conclusions:
- Understanding SWI/SNF complex function is vital for breast cancer research.
- Epigenetic targeting of SWI/SNF mutations may enhance treatment outcomes.
- Further research into SWI/SNF's therapeutic potential is warranted.
